Know Cancer

or
forgot password

Development of a Rapid Assessment Tool for Fatigue in Palliative Care


N/A
18 Years
N/A
Not Enrolling
Both
Neoplasms

Thank you

Trial Information

Development of a Rapid Assessment Tool for Fatigue in Palliative Care


Based on a series of qualitative studies, our group is developing a new rapid fatigue
assessment screening tool (rFAST) for use with individuals who have advanced cancer and are
receiving care in either an active treatment or palliative setting.

Hypotheses:

1. The three tools (tiredness, fatigue, and exhaustion) in the rFAST are each defined by
the same six dimensions: decline in stamina, decline in cognition, decline in sleep
quality, diminished social network, and increased emotional reactivity

2. The five subscales of the tiredness, fatigue, and exhaustion scales are internally
consistent.

3. Tiredness, fatigue, and exhaustion are distinct states that are manifested by unique
patterns of scores on their 6 subscales

4. The mean POMS-Vsf scores of individuals who meet the definition of fatigue will be
lower than the mean POMS-Vsf scores of individuals who meet the definition of tiredness
and higher than the mean POMS-Vsf scores of individuals who meet the definition of
exhaustion.

Objectives

1. To examine the factor structure of the tiredness, fatigue, and exhaustion scales of the
rFAST.

2. To examine the internal consistency of the 5 subscales within the tired, fatigue, and
exhaustion scales.

3. To compare actual rFAST scale scores to hypothesized scale profiles for tiredness,
fatigue, and exhaustion.


Inclusion Criteria:



- Patients with advanced cancer currently receiving treatment for either hematologic or
lung cancer at the Jewish General Hospital in Montreal, or patients with advanced
cancer currently receiving care through the Alberta Cancer Board (Cross Cancer
Institute or Tom Baker Cancer Centre), or the palliative care programs associated
with the regional health authority in Edmonton, Alberta who are at least 18 years
old, able to read and write English, have a Folstein Mini Mental Status Exam score of
at least 22.

Exclusion Criteria:

- Patients unable to give informed consent in English.

Type of Study:

Observational

Study Design:

Time Perspective: Prospective

Principal Investigator

Karin L Olson, Ph.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Alberta

Authority:

Canada: Canadian Institutes of Health Research

Study ID:

G118160539

NCT ID:

NCT00428675

Start Date:

October 2005

Completion Date:

October 2010

Related Keywords:

  • Neoplasms
  • screening
  • fatigue
  • Neoplasms
  • Fatigue

Name

Location